CA3236853A1 - Protein tyrosine phosphatase inhibitors and methods of use thereof - Google Patents
Protein tyrosine phosphatase inhibitors and methods of use thereof Download PDFInfo
- Publication number
- CA3236853A1 CA3236853A1 CA3236853A CA3236853A CA3236853A1 CA 3236853 A1 CA3236853 A1 CA 3236853A1 CA 3236853 A CA3236853 A CA 3236853A CA 3236853 A CA3236853 A CA 3236853A CA 3236853 A1 CA3236853 A1 CA 3236853A1
- Authority
- CA
- Canada
- Prior art keywords
- hydroxy
- fluoro
- dihydro
- benzothiopyran
- trione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278336P | 2021-11-11 | 2021-11-11 | |
| US63/278,336 | 2021-11-11 | ||
| PCT/US2022/049581 WO2023086495A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3236853A1 true CA3236853A1 (en) | 2023-05-19 |
Family
ID=84887566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3236853A Pending CA3236853A1 (en) | 2021-11-11 | 2022-11-10 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250042894A1 (https=) |
| EP (1) | EP4430039A1 (https=) |
| JP (1) | JP2024543451A (https=) |
| CN (1) | CN118556055A (https=) |
| AU (1) | AU2022386164A1 (https=) |
| CA (1) | CA3236853A1 (https=) |
| MX (1) | MX2024005656A (https=) |
| WO (1) | WO2023086495A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20252789A1 (es) | 2023-05-24 | 2025-12-22 | Kumquat Biosciences Inc | Compuestos heterociclicos y usos de estos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA94921C2 (en) * | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| BR112020026086A2 (pt) * | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
| IL286373B2 (en) * | 2019-03-14 | 2026-03-01 | Calico Life Sciences Llc | Protein tyrosine phosphate inhibitor compounds and uses thereof |
| CA3162069A1 (en) * | 2019-12-18 | 2021-06-24 | Elliot P. Farney | Protein tyrosine phosphatase inhibitors and methods of use thereof |
-
2022
- 2022-11-10 MX MX2024005656A patent/MX2024005656A/es unknown
- 2022-11-10 WO PCT/US2022/049581 patent/WO2023086495A1/en not_active Ceased
- 2022-11-10 JP JP2024527749A patent/JP2024543451A/ja active Pending
- 2022-11-10 US US18/709,204 patent/US20250042894A1/en active Pending
- 2022-11-10 AU AU2022386164A patent/AU2022386164A1/en active Pending
- 2022-11-10 EP EP22839527.3A patent/EP4430039A1/en active Pending
- 2022-11-10 CA CA3236853A patent/CA3236853A1/en active Pending
- 2022-11-10 CN CN202280088452.2A patent/CN118556055A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250042894A1 (en) | 2025-02-06 |
| AU2022386164A1 (en) | 2024-05-23 |
| MX2024005656A (es) | 2024-08-06 |
| EP4430039A1 (en) | 2024-09-18 |
| WO2023086495A1 (en) | 2023-05-19 |
| JP2024543451A (ja) | 2024-11-21 |
| CN118556055A (zh) | 2024-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2023201044A2 (en) | Jak inhibitor analogs, formulations, and uses thereof | |
| AU2023358081A1 (en) | Novel bicyclic heterocyclyl compounds and use thereof | |
| EP4479387A1 (en) | Inhibitors of parg | |
| WO2019127008A1 (zh) | 一种靶向降解btk的化合物及其应用 | |
| JP6807054B2 (ja) | 環状アミン誘導体及びその医薬用途 | |
| JP2009507816A (ja) | 抗ウィルス薬としての四環式インドール誘導体 | |
| KR20160062170A (ko) | 융합된 헤테로사이클릭 화합물, 이의 제조 방법, 약학적 조성물, 및 그 용도 | |
| KR20250047111A (ko) | Sos1 억제제로서의 신규한 프탈라진 유도체 화합물 및 이의 용도 | |
| EP3377060A1 (en) | Pyrazole compounds and methods of making and using same | |
| CA3236854A1 (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
| EP3400226A1 (en) | Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer | |
| JPWO2003082855A1 (ja) | 抗炎症剤 | |
| CN116583285B (zh) | N-(咪唑并[1,2-b]哒嗪-3-基)-1-环己基-2H-吲唑-5-甲酰胺和N-(吡唑并[1,5-a]嘧啶-3-基)-1-环己基-2H-吲唑-5-甲酰胺衍生物作为IRAK4抑制剂用于治疗哮喘 | |
| CA3236853A1 (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
| CA3183575A1 (en) | Ampk activators | |
| EP3759113B1 (en) | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza | |
| AU2020374041A1 (en) | EED inhibitor, and preparation method therefor and use thereof | |
| US11718615B2 (en) | Heterocyclic compounds and their application in medicine | |
| AU2015215582B2 (en) | Azaindole derivative | |
| WO2022236257A1 (en) | Heterocyclic compounds as kinase inhibitors | |
| WO2025171259A1 (en) | Compounds, compositions, and methods for the treatment of diseases | |
| WO2023248010A2 (en) | Targeted modulators of jak3 for treatment of inflammatory and autoimmune diseases | |
| HK40042824B (en) | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza | |
| HK40042824A (en) | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9a,10-tetrahydro-7h-pyrrolo[1',2':4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza | |
| NZ626745B2 (en) | Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251031 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251031 |